12-May-2025 5:00 AM CST - Business Wire Organigram Reports Record Second Quarter Fiscal 2025 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (Q2 Fiscal 2025). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in
2-May-2025 5:00 AM CST - Business Wire Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi
22-Apr-2025 5:00 AM CST - Business Wire Organigram Global Shares Recording of its OG Investor Session Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram Global), Canadas #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. This session was a way for Organigram to engage directly with investors and industry stak
2-Apr-2025 5:00 AM CST - Business Wire Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram Global), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Globals next chapter. Attendees will gain valuable insights into the Companys growth trajectory, engage directly with leadership on key ind
11-Feb-2025 5:00 AM CST - Business Wire Organigram Reports First Quarter Fiscal 2025 Results Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (Q1 Fiscal 2025). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. ("Motif") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif. Q1 FISCAL 2025 HIGHLIGHTS Net revenue increased 17% to $42.7 million from $36.5 mill
4-Feb-2025 5:00 PM CST - Business Wire Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the Company or Organigram), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2025 ended December 31, 2024, on Tuesday, February 11, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 11, 2025 Time: 8:00 am Easte
18-Dec-2024 5:00 AM CST - Business Wire Organigram Reports Fourth Quarter and Fiscal 2024 Results Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), a leading licensed producer (LP) of cannabis, announced its results for the fourth quarter and twelve months ended September 30, 2024 (Q4 Fiscal 2024 or Fiscal 2024). All financial information in this press release is expressed in Canadian dollars ($). Comparable Periods: The Company's results for Q4 Fiscal 2024 and Fiscal 2024 reflect the three-month and 12-month periods ended
11-Dec-2024 5:00 AM CST - Business Wire Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the Company or Organigram), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, December 18, 2024 Time: 8:0
12-May-2025 5:00 AM CST - Business Wire Organigram Reports Record Second Quarter Fiscal 2025 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (Q2 Fiscal 2025). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in
2-May-2025 5:00 AM CST - Business Wire Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi
22-Apr-2025 5:00 AM CST - Business Wire Organigram Global Shares Recording of its OG Investor Session Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram Global), Canadas #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. This session was a way for Organigram to engage directly with investors and industry stak
2-Apr-2025 5:00 AM CST - Business Wire Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram Global), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Globals next chapter. Attendees will gain valuable insights into the Companys growth trajectory, engage directly with leadership on key ind
11-Feb-2025 5:00 AM CST - Business Wire Organigram Reports First Quarter Fiscal 2025 Results Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (Q1 Fiscal 2025). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. ("Motif") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif. Q1 FISCAL 2025 HIGHLIGHTS Net revenue increased 17% to $42.7 million from $36.5 mill
4-Feb-2025 5:00 PM CST - Business Wire Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the Company or Organigram), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2025 ended December 31, 2024, on Tuesday, February 11, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 11, 2025 Time: 8:00 am Easte
18-Dec-2024 5:00 AM CST - Business Wire Organigram Reports Fourth Quarter and Fiscal 2024 Results Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), a leading licensed producer (LP) of cannabis, announced its results for the fourth quarter and twelve months ended September 30, 2024 (Q4 Fiscal 2024 or Fiscal 2024). All financial information in this press release is expressed in Canadian dollars ($). Comparable Periods: The Company's results for Q4 Fiscal 2024 and Fiscal 2024 reflect the three-month and 12-month periods ended
11-Dec-2024 5:00 AM CST - Business Wire Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the Company or Organigram), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, December 18, 2024 Time: 8:0
